Evotec stock gains 9.51 percent ahead of November 5 results


Evotec stock gains 9.51 percent over the week as results ...

Evotec stock: At 61.23 percent below its 52-week high Evotec ...

Berenberg keeps EUR 3.60 target for Evotec stock

Evotec stock at EUR 2.81 ahead of the Xetra open: drug discovery ...

Evotec stock: RBC keeps EUR 10.00 target for Evotec stock ...

Evotec appoints Joanna Holbrook as chief scientific officer. ...

Evotec stock at EUR 2.77 ahead of the Xetra open: drug group ...

Evotec stock: At 63.29 percent below its high Evotec stock ...

Berenberg keeps EUR 3.60 target for Evotec stock